OUEH Investments Pte. Ltd. made an offer to acquire Healthway Medical Corporation Limited (Catalist:5NG) from GW Active Limited and others for approximately SGD 220 million on July 3, 2023. The transaction is subject to approval from target shareholders, de-listing of target shares and minimum tender of 50%. In addition, the delisting will also be conditional upon the SGX-ST agreeing to the application by Healthway Medical Corporation to delist from the Official List of the Catalist Board of the SGX-ST. As of September 27, 2023, the minimum acceptance has been achieved. As of September 29, 2023, the offer has become unconditional.

Oversea-Chinese Banking Corporation Limited (SGX:O39) acted financial advisor for OUE Healthcare Limited. Xandar Capital Pte. Ltd. acted as financial advisor Healthway. Boardroom Corporate & Advisory Services Pte. Ltd. acted as transfer agent to Healthway Medical Corporation. The Central Depository (Pte) Limited acted as Depository to Healthway Medical Corporation.

OUEH Investments Pte. Ltd. completed the acquisition of 68.53% stake in Healthway Medical Corporation Limited (Catalist:5NG) from GW Active Limited and others on October 26, 2023.